• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS LUCERA GASTROINTESTINAL VIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS LUCERA GASTROINTESTINAL VIDEOSCOPE Back to Search Results
Model Number GIF-Q260J
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001); Stenosis (2263); Muscle/Tendon Damage (4532)
Event Date 08/02/2022
Event Type  Injury  
Manufacturer Narrative
This report is related to the following linked patient identifiers: (b)(6).The device was not returned.Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
Olympus reviewed the following literature titled "outcomes of endoscopic submucosal dissection in patients who develop metachronous superficial esophageal squamous cell carcinoma close to a post-endoscopic submucosal dissection scar".Literature summary: background the presence of post-endoscopic submucosal dissection (esd) scars renders complete metachronous superficial esophageal squamous cell carcinoma resection difficult.We aimed to identify the risk factors for incomplete resection of metachronous esophageal squamous cell carcinoma close to the post-esd scar by esd.Methods: we enrolled patients who developed post-esd superficial esophageal squamous cell carcinoma at hiroshima university hospital between (b)(6) 2006 and (b)(6) 2020.We analyzed the outcomes and risk factors of incomplete resection between patients whose lesions were close to (close-to group) and away from (away-from group) the post-esd scar.Procedure-related perforation was identified endoscopically or by the presence of free air on a plain chest radiograph and chest computed tomography.Endoscopic clipping was used to treat intraoperative perforation.Bleeding during esd was defined as bleeding that was controlled using hemostatic measures during the endoscopic procedure.Delayed bleeding was defined as a decrease in hemoglobin levels by 2 g/dl or more relative to the last recorded preoperative hemoglobin level or any apparent bleeding or massive melena occurring after esd.Damage to the muscle layer was defined as injury to the inner muscle ring during esd.Perforation was defined as the presence of a visible hole in the esophageal wall, exposing the mediastinal space, during the endoscopic procedure.Stenosis was defined as the requirement of balloon dilation in the treated area after esd.Results we included (b)(4) lesions.The close-to group had a significantly lower complete resection rate(b)(4).Conclusions complete resection was more difficult for lesions located on the oral side of the post-esd scar.Type of adverse events/number of patients: number of patients after propensity score matching.Bleeding during esd - (b)(4).Damage of muscle layer - (b)(4).Perforation - (b)(4).Stenosis - (b)(4).
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA GASTROINTESTINAL VIDEOSCOPE
Type of Device
GASTROINTESTINAL VIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key18750314
MDR Text Key335935853
Report Number9610595-2024-03655
Device Sequence Number1
Product Code FDS
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/21/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGIF-Q260J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/11/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
D-201-11804/UNKNOWN LOT NO.; FD-410LR/UNKNOWN LOT NO.; KD-650L/UNKNOWN LOT NO.; KD-655L/UNKNOWN LOT NO.; WB991046/UNKNOWN SERIAL NO.
Patient Outcome(s) Required Intervention;
-
-